U.S. market Open. Closes in 12 minutes

ITOS | iTeos Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue12.60M267.63M344.77MN/AN/AN/A
Cost of Revenue898.00K813.00K615.00K535.00K611.00KN/A
Gross Profit11.70M266.82M344.16M-535.00K-611.00KN/A
Operating Expenses157.48M138.04M89.69M39.31M23.27M17.82M
Selling, General & Admin50.40M43.95M40.51M15.34M8.84M4.31M
Research & Development113.30M97.36M59.37M29.90M19.21M17.19M
Other Operating Expenses4.08M-3.26M-10.18M-5.93M-4.78M-163.00K
Operating Income-151.10M126.32M244.90M-45.24M-28.05M-21.50M
Other Expenses / Income4.08M22.41M11.56M7.15M5.71M-163.00K
Before Tax Income-109.03M148.74M256.46M-38.09M-22.34M-18.05M
Income Tax Expenses3.61M52.08M41.94M-57.00K119.00K11.00K
Net Income-112.64M96.65M214.52M-38.03M-22.45M-18.06M
Interest ExpensesN/A-19.15MN/AN/AN/A66.00K
Basic Shares Outstanding35.76M35.55M35.18M35.04M35.02M7.51M
Diluted Shares Outstanding35.76M37.77M37.77M35.04M35.02M7.51M
EBITDA-143.99M130.39M255.69M-38.77M-21.72M-17.48M
EBITDA Margin-1,143.22%48.72%74.16%0.00%0.00%0.00%
EBIT-109.03M129.59M256.46M-38.09M-22.34M-17.98M
EBIT Margin-865.66%48.42%74.39%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙